NAM Leadership Consortium AICC Commentary Paper: Public Comment
NAM Leadership Consortium AICC Commentary Paper: Public Comment.
NAM Leadership Consortium AICC Commentary Paper: Public Comment.
The present case studies report malignant neoplastic and traumatic lesions observed on two ancient Egyptian skulls held at the Duckworth Collection (Cambridge University). The analysis…
An extraordinary discovery.
Hiring ‘vibe lifters’ is no bad thing – but it does come with pitfalls
In modern cancer drug development, surrogate measures are commonly used as clinical trial endpoints instead of more definitive clinical outcomes such as overall survival, with…
On April 18, 2024, WHO launched the first ever Patient Safety Rights Charter to delineate patient rights regarding health and safety and to support the…
Nature Communications – Anecdotal reports from patients prescribed semaglutide describe a reduced desire to drink. Here, the authors show that semaglutide is associated with a…
Benjamin Avi Derman University of Chicago, Chicago, IL Benjamin Avi Derman, Jennifer H. Cooperrider, Tadeusz Kubicki, Ajay Major, Ken Jiang, Aubrianna Ramsland, Karson Buckley, Samrawit…
Paula Rodríguez-Otero Department of Hematology, Cancer Center Clínica Universidad de Navarra, Pamplona, Spain Paula Rodríguez-Otero, Philippe Moreau, Meletios Athanasios Dimopoulos, Meral Beksac, Aurore Perrot, Annemiek…
Reduce emissions, build resilience, repair ecosystems, remove greenhouse gases: these are the four Rs that can save us, says David King, chair of the global…
Introduction Deprescribing ( medication dose reduction or cessation ) is an integral component of appropriate prescribing. The extent to which deprescribing recommendations are included in…